|4Jun 28, 6:03 PM ET

Eastern Capital LTD 4

4 · iBio, Inc. · Filed Jun 28, 2018

Insider Transaction Report

Form 4
Period: 2018-06-26
Transactions
  • Purchase

    Series B Preferred Shares

    2018-06-26$1000.00/sh+5,785$5,785,0005,785 total
    Common Stock (6,427,778 underlying)
  • Purchase

    Common Shares

    2018-06-26$0.90/sh+1,683,334$1,515,0016,257,734 total
Footnotes (2)
  • [F1]Eastern Capital Limited acquired 1,683,334 shares of Common Stock of the Issuer (the "Shares") at a price of $0.90 per share and 5,785 Series B Preferred Shares at an offering price of $1,000 per Series B Preferred Share on June 26, 2018, in an underwritten public offering.
  • [F2]The Series B Preferred Shares is convertible into Shares at the option of Eastern Capital Limited, at any time, at a conversion price equal to the public offering price of the Shares, and are subject to a limit of exercise to the extent (and only to the extent) that Eastern Capital Limited or any of its affiliates would beneficially own in excess of 48% of the Shares after giving effect to such exercise.

Documents

1 file
  • 4
    ecl_ibioform406282018.xmlPrimary

    OWNERSHIP DOCUMENT